GELTEQ LIMITED ORDINARY SHARES

NASDAQ: GELS (Gelteq Limited)

Last update: 3 days ago, 11:15PM

0.757

0.01 (1.15%)

Previous Close 0.748
Open 0.725
Volume 9,643
Avg. Volume (3M) 1,042,366
Market Cap 8,103,988
Price / Sales 59.33
Price / Book 0.720
52 Weeks Range
0.670 (-11%) — 4.11 (443%)
Operating Margin (TTM) -2,518.17%
Diluted EPS (TTM) -0.350
Quarterly Revenue Growth (YOY) 56.80%
Total Debt/Equity (MRQ) 25.43%
Current Ratio (MRQ) 0.080
Operating Cash Flow (TTM) -1.07 M
Return on Assets (TTM) -8.04%
Return on Equity (TTM) -21.00%

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Mixed Mixed
Drug Manufacturers - Specialty & Generic (Global) Mixed Mixed
Stock Gelteq Limited - -

AIStockmoo Score

0.1
Analyst Consensus 0.0
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 2.5
Technical Oscillators -2.5
Average 0.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
GELS 8 M - - 0.720
KNSA 4 B - 105.31 6.30
HROW 2 B - - 42.55
BCRX 2 B - - 56.59
AMLX 2 B - - 5.05
ALVO 1 B - 19.09 -

Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Investment Style Small Growth
% Held by Insiders 60.36%
% Held by Institutions 1.11%

Ownership

Name Date Shares Held
Wedbush Securities Inc 31 Dec 2025 20,000

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria